Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

It has a solid safety profile, but Ozempic does have common side effects, which include gastrointestinal issues like nausea, diarrhea and constipation. Because Zepbound and Ozempic work ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

In Canada, where the diabetes version of Zepbound, called Mounjaro, is available in vials, there haven’t been any marked safety concerns, said Lawrence A. Leiter, MD, a professor of medicine and ...

Zepbound, a brand-name version of tirzepatide ... which have been riddled with safety concerns but are nonetheless relied on for their relative affordability and accessibility.

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

On the other hand, any setbacks (e.g., postmarketing Zepbound safety concerns) could significantly derail its valuation. Finally, I conduct a Monte Carlo simulation to account for variability in ...